Page last updated: 2024-09-04

tariquidar and isoniazid

tariquidar has been researched along with isoniazid in 1 studies

Compound Research Comparison

Studies
(tariquidar)
Trials
(tariquidar)
Recent Studies (post-2010)
(tariquidar)
Studies
(isoniazid)
Trials
(isoniazid)
Recent Studies (post-2010) (isoniazid)
2101613821,8159604,493

Protein Interaction Comparison

ProteinTaxonomytariquidar (IC50)isoniazid (IC50)
MyeloperoxidaseHomo sapiens (human)4.85
Enoyl-[acyl-carrier-protein] reductase [NADH]Mycobacterium tuberculosis H37Rv8.29
Putative FAD-containing monooxygenase MymAMycobacterium tuberculosis H37Rv4.9

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Back, DJ; Bertel Squire, S; Chandler, B; Hartkoorn, RC; Khoo, SH; Owen, A; Ward, SA1

Other Studies

1 other study(ies) available for tariquidar and isoniazid

ArticleYear
Differential drug susceptibility of intracellular and extracellular tuberculosis, and the impact of P-glycoprotein.
    Tuberculosis (Edinburgh, Scotland), 2007, Volume: 87, Issue:3

    Topics: Antitubercular Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Survival; Cells, Cultured; Colorimetry; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Indicators and Reagents; Isoniazid; Macrophages; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazines; Phagocytosis; Quinolines; Rifampin; Spectrometry, Fluorescence; Tuberculosis; Xanthenes

2007